Full-Time
Aetna Pharmacy Performance Analytics
Manager
Posted on 9/18/2025
CVS Health
10,001+ employees
Healthcare, insurance, PBM, and retail pharmacy
Compensation Overview
$54.3k - $159.1k/yr
Company Historically Provides H1B Sponsorship
Salt Lake City, UT, USA + 48 more
More locations: Madison, WI, USA | Boston, MA, USA | Olympia, WA, USA | Indianapolis, IN, USA | Bismarck, ND, USA | Des Moines, IA, USA | Nashville, TN, USA | Harrisburg, PA, USA | Washington, DC, USA | Austin, TX, USA | Augusta, ME, USA | Providence, RI, USA | Onida, SD, USA | Jackson, MS, USA | Lincoln, NE, USA | Raleigh, NC, USA | East Lansing, MI, USA | Frankfort, KY, USA | Richmond, VA, USA | Annapolis, MD, USA | Tallahassee, FL, USA | Salem, OR, USA | Concord, NH, USA | Topeka, KS, USA | Boise, ID, USA | Carson City, NV, USA | Trenton, NJ, USA | Little Rock, AR, USA | Sacramento, CA, USA | Albany, NY, USA | Cheyenne, WY, USA | Santa Fe, NM, USA | Columbus, OH, USA | Hartford, CT, USA | Springfield, IL, USA | Oklahoma City, OK, USA | Baton Rouge, LA, USA | Jefferson City, MO, USA | Phoenix, AZ, USA | Denver, CO, USA | Columbia, SC, USA | Montpelier, VT, USA | Atlanta, GA, USA | Helena, MT, USA | St Paul, MN, USA | Dover, DE, USA | Charleston, WV, USA | Montgomery, AL, USA
Remote
Position can be remote or hybrid if you live within a commutable distance to an office.
 Medical, Clinical & Veterinary (1) |
|---|
- A minimum of 3 years of relevant experience in finance or other data-driven roles within a healthcare environment.
- Experience in SAS, SQL, GCP (must have ability to write code to manipulate data).
- Ability to think creatively and use multiple data sources to assess and develop business strategies.
- Ability to effectively manage multiple priorities.
- Ability to collaborate with experts from other teams to better understand issues/drivers and how/why the impact may differ by line of business.
- Proficient with Microsoft Office products (i.e. Excel).
- Experience with large and detailed data sets.
- Expand and maintain KPI metrics dashboards that provide senior leadership standardized, meaningful, and transparent reporting into performance of the pharmacy business. Exhibit innovative use of resources
- Gain deep understanding of KPIs and how strategic initiatives may impact performance
- Create succinct executive-level presentations that drive organizational awareness and engagement
- Leverage various internal and external data sources to build succinct management process to identify drivers and areas of opportunities underlying performance metrics
- Apply project management/organizational skills to execute contracting changes or correction plans and communicate succinctly to cross-functional workgroups
- Develop strategic relationships with all Aetna LOBs to create transparency and improve organizational knowledge of KPI performance
- Develop creative technical solutions to incorporate efficiencies into daily work.
- Experience in pharmacy-related work.
- Business knowledge of different Aetna segments and how unique components within each line of business impact P&L performance.
CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.
Company Size
10,001+
Company Stage
IPO
Headquarters
Woonsocket, Rhode Island
Founded
1963
Simplify's Take
What believers are saying
- Aetna drove Q1 2026 operating income to $3 billion, raising EPS guidance to $7.30-$7.50.
- Health100 AI platform with Google Cloud enhances personalized care and efficiency.
- Pharmacy-only stores expand to 20 sites in 2026, targeting underserved Chicago, Houston areas.
What critics are saying
- Aetna pays $117.7M DOJ settlement for Medicare Advantage diagnosis fraud in May 2026.
- FTC insulin settlement forces Caremark rebate transparency, compressing PBM margins by 2027.
- Walgreens VillageMD and Walmart clinics erode CVS retail pharmacy market share in 2026.
What makes CVS Health unique
- CVS Health integrates Aetna insurance, Caremark PBM, and 9,000 retail pharmacies into closed-loop care.
- Specialty units like Accordant and Coram serve 45,000 patients monthly for complex conditions.
- HealthHub kiosks and MinuteClinics pilot preventive care in Atlanta, Houston, Philadelphia.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Company Equity
Wellness Program
Professional Development Budget
Paid Vacation
Paid Holidays
Company News
CVS Health has opened its first pharmacy-only location in Chicago, part of plans to launch nearly 20 such sites across the US this year. The 3,000-square-foot store at 2628 West Pershing Road features a full-service pharmacy with selected over-the-counter products. The pharmacy-only format is designed to increase access to medications, immunizations and pharmacist consultations in underserved communities. Additional locations are planned for Houston, Roxbury, Detroit and Brooklyn in 2026, alongside more than 40 traditional CVS Pharmacy stores. The move responds to consumer preferences, with CVS's 2025 research showing 80% of patients prefer face-to-face pharmacy care and 48% would switch pharmacies if limited to digital-only options. The company opened its first pharmacy-only site in Birmingham, Alabama, late last year.
CVS Health has reached a proposed settlement with the Federal Trade Commission over insulin pricing practices at its Caremark pharmacy benefit manager unit. The company also declared a quarterly dividend of $0.665 per share, payable on 4 May 2026. The settlement places CVS's pharmacy benefit management model under increased regulatory scrutiny regarding drug cost transparency. The company's investment narrative centres on its integrated model across insurance, pharmacy and care delivery, with near-term focus on restoring profitability in healthcare delivery and PBM services. CVS recently appointed former Elevance Health CFO John E. Gallina to its board as an audit committee financial expert. The company's narrative projects $445.5 billion revenue and $10.2 billion earnings by 2029, implying a fair value of $96.50 per share.
Bernstein analyst Lance Wilkes upgraded CVS Health to "Outperform" from "Market Perform" on 12 March, raising the price target to $94 from $91. The upgrade reflects the company's attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in its pharmacy and pharmacy benefit manager businesses following reforms. Wilkes cited the PBM bill passage and the Federal Trade Commission settlement with Cigna as clearing events for the stock. Separately, CVS Health announced a strategic partnership with Google Cloud focused on reimagining healthcare experiences through its new health technology subsidiary, Health100, which will offer AI-powered healthcare services. CVS Health operates as a diversified healthcare company combining insurance, pharmacy benefit management, retail pharmacies and clinical services across the United States.
Aetna, a CVS Health subsidiary, has agreed to pay $117.7 million to the US Department of Justice to settle allegations that it submitted inaccurate diagnosis codes for Medicare Advantage members to increase reimbursements. The settlement resolves longstanding False Claims Act allegations related to the Medicare Advantage programme. CVS Health shares recently closed at $76.07, down 5.1% year-to-date, though up 20.1% over the past year. The settlement is material for the company, which has thin net margins of 0.4% and debt not well covered by operating cash flow. The agreement highlights compliance risks in CVS Health's government-facing insurance operations, a central part of its Medicare Advantage business. Analysts' average target price stands at $96.50, approximately 27% above current levels.
Alphabet faces a wrongful death lawsuit alleging its Gemini AI chatbot contributed to a user's suicide, reportedly the first legal case directly linking Google's AI tools to a death. Simultaneously, the company announced a healthcare AI partnership with CVS Health focused on a real-time consumer engagement platform. The contrasting developments underscore Alphabet's expanding role in high-stakes sectors. The CVS collaboration integrates Gemini into Health100, a platform handling personal interactions across insurers, pharmacies and care providers. Meanwhile, the lawsuit tests whether conversational AI design and crisis protocols carry a duty of care, even outside formal healthcare settings. For investors, the key questions centre on how Alphabet manages legal risk, establishes guardrails and navigates regulatory oversight as its AI tools penetrate sectors requiring heightened safety and compliance standards.